114 related articles for article (PubMed ID: 15648930)
1. New vaccine to fight feline FIV.
Aust Vet J; 2004 Dec; 82(12):730. PubMed ID: 15648930
[No Abstract] [Full Text] [Related]
2. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
Kahler SC;
J Am Vet Med Assoc; 2002 Nov; 221(9):1231-4. PubMed ID: 12418682
[No Abstract] [Full Text] [Related]
3. FIV vaccine recommendation.
Conway T
J Am Vet Med Assoc; 2003 Mar; 222(5):580. PubMed ID: 12619832
[No Abstract] [Full Text] [Related]
4. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
5. Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
Dunham SP; Bruce J; MacKay S; Golder M; Jarrett O; Neil JC
Vet Rec; 2006 Apr; 158(16):561-2. PubMed ID: 16632531
[No Abstract] [Full Text] [Related]
6. Vaccine protection against feline immunodeficiency virus: setting the challenge.
Hosie MJ; Beatty JA
Aust Vet J; 2007; 85(1-2):5-12; quiz 85. PubMed ID: 17300445
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against the feline immunodeficiency virus: the road not taken.
Lecollinet S; Richardson J
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
Hesselink W; Sondermeijer P; Pouwels H; Verblakt E; Dhore C
Vet Microbiol; 1999 Sep; 69(1-2):109-10. PubMed ID: 10515278
[TBL] [Abstract][Full Text] [Related]
9. The development of a vaccine against feline immunodeficiency virus.
Hosie MJ
Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
[TBL] [Abstract][Full Text] [Related]
10. Vaccine protection against feline immunodeficiency virus: setting the challenge.
Zwijnenberg R; Yamamoto JK
Aust Vet J; 2007 Jun; 85(6):210-1. PubMed ID: 17547630
[No Abstract] [Full Text] [Related]
11. Experimental vaccine protection against feline immunodeficiency virus.
Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a feline immunodeficiency virus vaccine.
Huang C; Conlee D; Loop J; Champ D; Gill M; Chu HJ
Anim Health Res Rev; 2004 Dec; 5(2):295-300. PubMed ID: 15984343
[TBL] [Abstract][Full Text] [Related]
13. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
Stickney A; Ghosh S; Cave NJ; Dunowska M
Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
[TBL] [Abstract][Full Text] [Related]
14. Feline immunodeficiency virus diagnosis after vaccination.
Andersen PR; Tyrrell P
Anim Health Res Rev; 2004 Dec; 5(2):327-30. PubMed ID: 15984349
[TBL] [Abstract][Full Text] [Related]
15. Vaccine protection against feline immunodeficiency virus.
Hosie MJ; Beatty JA
Aust Vet J; 2007 Aug; 85(8):302-3. PubMed ID: 17685973
[No Abstract] [Full Text] [Related]
16. SIV and FIV vaccine studies at UC Davis: 1991 update.
Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
[No Abstract] [Full Text] [Related]
17. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
[TBL] [Abstract][Full Text] [Related]
18. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
19. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.
Giannecchini S; Isola P; Sichi O; Matteucci D; Pistello M; Zaccaro L; Del Mauro D; Bendinelli M
J Virol; 2002 Jul; 76(14):6882-92. PubMed ID: 12072489
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on FIV vaccine development.
Elyar JS; Tellier MC; Soos JM; Yamamoto JK
Vaccine; 1997; 15(12-13):1437-44. PubMed ID: 9302758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
